Foghorn Therapeutics logo

Foghorn Therapeutics Share Price Today

(NASDAQ: FHTX)

Foghorn Therapeutics share price is $4.67 & ₹406.15 as on 6 Mar 2025, 2.30 'hrs' IST

$4.67

0.28

(6.38%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Foghorn Therapeutics share price in Dollar and Rupees. Guide to invest in Foghorn Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Foghorn Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Foghorn Therapeutics share price movements

  • Today's Low: $4.30
    Today's High: $4.75

    Day's Volatility :9.52%

  • 52 Weeks Low: $3.86
    52 Weeks High: $10.25

    52 Weeks Volatility :62.34%

Foghorn Therapeutics (FHTX) Returns

PeriodFoghorn Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-28.48%
3.7%
0.0%
6 Months
-42.2%
-2.8%
0.0%
1 Year
-31.22%
2.5%
0.0%
3 Years
-48.11%
12.9%
-11.6%

Foghorn Therapeutics (FHTX) Key Statistics

in dollars & INR

Previous Close
$4.39
Open
$4.36
Today's High
$4.7525
Today's Low
$4.3
Market Capitalization
$244.1M
Today's Volume
$91.2K
52 Week High
$10.25
52 Week Low
$3.86
Revenue TTM
$25.5M
EBITDA
$-98.5M
Earnings Per Share (EPS)
$-1.87
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-470.38%

How to invest in Foghorn Therapeutics Stock (FHTX) from India?

It is very easy for Indian residents to invest directly in Foghorn Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Foghorn Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Foghorn Therapeutics or FHTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Foghorn Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Foghorn Therapeutics shares which would translate to 0.186 fractional shares of Foghorn Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Foghorn Therapeutics, in just a few clicks!

Returns in Foghorn Therapeutics (FHTX) for Indian investors in Rupees

The Foghorn Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Foghorn Therapeutics investment value today

Current value as on today

₹73,726

Returns

₹26,274

(-26.27%)

Returns from Foghorn Therapeutics Stock

₹31,222 (-31.22%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Foghorn Therapeutics (FHTX)

71%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Foghorn Therapeutics Stock from India on INDmoney has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Foghorn Therapeutics

  • Flagship Ventures Management, Inc.

    22.79%

  • FMR Inc

    10.23%

  • Bvf Inc

    9.53%

  • Deerfield Management Co

    5.85%

  • Raymond James & Associates

    4.13%

  • BlackRock Inc

    3.65%

Analyst Recommendation on Foghorn Therapeutics

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Foghorn Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Foghorn Therapeutics Stock (FHTX)

What analysts predicted

Upside of 150.84%

Target:

$11.71

Current:

$4.67

Insights on Foghorn Therapeutics Stock (Ticker Symbol: FHTX)

  • Price Movement

    In the last 1 month, FHTX stock has moved up by 13.3%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 5.05M → 7.80M (in $), with an average increase of 19.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -25.01M → -19.12M (in $), with an average increase of 14.5% per quarter
  • FHTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 97.7%
  • FHTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 99.7%
  • Price to Sales

    ForFHTX every $1 of sales, investors are willing to pay $9.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Foghorn Therapeutics Technicals Summary

Sell

Neutral

Buy

Foghorn Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Foghorn Therapeutics (FHTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Foghorn Therapeutics Inc logo
13.63%
-42.2%
-31.22%
-48.11%
-74.23%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Foghorn Therapeutics Inc logo
NA
NA
NA
-1.48
-4.7
-0.2
NA
-0.51
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Foghorn Therapeutics Inc logo
Buy
$244.1M
-74.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Foghorn Therapeutics

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It develops FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM that is in phase I for the treatment of relapsed and/or refractory acute myeloid leukemia/myelodysplastic syndrome. The company is also developing therapies for mutant cancers, such as Non-Small Cell Lung, bladder, endometrial, colorectal, and melanoma cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Foghorn Therapeutics
Employees
116
CEO
Ms. Karin Hellsvik
Industry
Health Technology

Management People of Foghorn Therapeutics

NameTitle
Mr. Adrian H. B. Gottschalk
President, CEO & Director
Dr. Steven F. Bellon Ph.D.
Chief Scientific Officer
Dr. Alfonso Quintas Cardama M.D.
Chief Medical Officer
Dr. Gerald R. Crabtree M.d.
Founder & Member of Scientific Advisory Board
Mr. Kristian Humer M.B.A.
Chief Financial Officer
Ms. Karin Hellsvik
Chief of Staff to the CEO, VP of Corporate Affairs & Investor Relations
Mr. Michael J. LaCascia J.D.
Chief Legal Officer
Mr. Saurabh Sewak Ph.D.
Vice President of Corporate Development
Mr. Carlos Costa
Chief People Officer
Dr. Anna Rivkin Ph.D.
Chief Business Officer

Important FAQs about investing in FHTX Stock from India :

What is Foghorn Therapeutics share price today?

Foghorn Therapeutics share price today stands at $4.67, Open: $4.36 ; Previous Close: $4.39 ; High: $4.75 ; Low: $4.30 ; 52 Week High: $10.25 ; 52 Week Low: $3.86.

The stock opens at $4.36, after a previous close of $4.39. The stock reached a daily high of $4.75 and a low of $4.30, with a 52-week high of $10.25 and a 52-week low of $3.86.

Can Indians buy Foghorn Therapeutics shares?

Yes, Indians can invest in the Foghorn Therapeutics (FHTX) from India.

With INDmoney, you can buy Foghorn Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Foghorn Therapeutics at zero transaction cost.

How can I buy Foghorn Therapeutics shares from India?

It is very easy to buy Foghorn Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Foghorn Therapeutics (FHTX) be purchased?

Yes, you can buy fractional shares of Foghorn Therapeutics with INDmoney app.

What are the documents required to start investing in Foghorn Therapeutics stocks?

To start investing in Foghorn Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Foghorn Therapeutics Stock (FHTX)?

Today’s highest price of Foghorn Therapeutics (FHTX) is $4.75.

Today’s lowest price of Foghorn Therapeutics (FHTX) is $4.30.

What is today's market capitalisation of Foghorn Therapeutics?

Today's market capitalisation of Foghorn Therapeutics FHTX is 244.1M

What is the 52 Week High and Low Range of Foghorn Therapeutics Stock (FHTX)?

  • 52 Week High

    $10.25

  • 52 Week Low

    $3.86

What are the historical returns of Foghorn Therapeutics (FHTX)?

  • 1 Month Returns

    13.63%

  • 3 Months Returns

    -42.2%

  • 1 Year Returns

    -31.22%

  • 5 Years Returns

    -74.23%

Who is the Chief Executive Officer (CEO) of Foghorn Therapeutics ?

Ms. Karin Hellsvik is the current Chief Executive Officer (CEO) of Foghorn Therapeutics.